The ZAHORANSKY Group acquired the dialysis division of its long-standing partner FLG Automation AG on January 1, 2021, taking a decisive step in consolidating its position in the field of medical technology. The complete lines for dialysis filter manufacturing from FLG perfectly complement the available know-how and existing portfolio of ZAHORANSKY concerning machines and installations for medical-technical products, as well as primary pharmaceutical packaging. With the acquisition, ZAHORANSKY offers the “one-stop shopping” experience its customers already know from brush production. In the future, this concept will also cover the installations for the production of dialyzers, the necessary injection molds for all parts, as well as the packaging machines.
The ZAHORANSKY range will comprise turn-key production systems for the manufacturing of dialyzers, also covering the quality checks that are indispensable in medical technology. The acquisition of the dialysis division was made possible as part of the succession plan for FLG founder, Lüdger Grünewald.
Ulrich Zahoransky says, “We have already been cooperating with FLG for many years. Real friendships have developed between our companies over time, also at a personal level. This makes me all the more delighted to have found a solution that works for both parties, creating a classic win-win situation.”
To ensure a seamless transition period, all requests by FLG customers and interested parties will be forwarded to ZAHORANSKY and answered by the same from January 1, 2021. The lion’s share of service and support activities can from now on be assumed through VPN remote services, with ZAHORANSKY benefiting from the support of the team at FLG. Lüdger Grünewald will also be available to the ZAHORANSKY Group in the coming years, as a consultant. He says, “I am already delighted by even more intensive collaboration in future, as well as by the opportunity to put my extensive know-how to great use.”
With its global sales and service subsidiaries in the US, India, China, Japan, and Brazil, ZAHORANSKY will also be able to provide competent customer support for these systems on a great number of key markets in the near future. The medical technology activities of the corporate group are bundled in ZAHORANSKY Automation & Molds GmbH in Freiburg, Germany.
A Success Story: Medical Technology by ZAHORANSKY
Over the past fifteen years, ZAHORANSKY has developed its activities in medical technology – parallel to its traditional line of business, injection molds and machines for brush production. Besides automatic lines for the production of suitable primary packaging, the company above all made a name for itself with machines for the production of staked-needle syringes, plastic syringes with a molded-over needle. The needles are not glued onto the syringe but rather molded over the syringe in a fully automatic process, benefiting both their stability and material compatibility while allowing for an efficient production process. With the acquisition of FLG production lines for dialyzers, ZAHORANSKY is now adding great competence to this field of business. The company achieves one of its most significant successes in this field at the beginning of 2020: US company SiO2 placed an initial order with ZAHORANSKY of 25 million euros for eleven automation lines and six removal units for coronavirus vaccine vials. Over the course of the year, the order was extended to an overall scope of 48 million euros. As part of the US government project “Operation Warp Speed”, 300 million coronavirus vaccine doses should be available by the beginning of the year. In spite of extremely short delivery times, ZAHORANSKY managed to meet the order in time and the machines were punctually put into operation with the customer.